Dermatology Advisor Examines Clinician Views on Biosimilar Shift
Dermatology Advisor surveys how dermatologists view biosimilar adoption, non-medical switching, and formulary pressure as competition expands across biologic classes.
Topic
Biosimilars
Topic
Biosimilars
Biosimilar CT-P43 Matches Ustekinumab for Moderate to Severe Plaque Psoriasis
Biosimilar CT-P43 has matched ustekinumab in treating moderate to severe plaque psoriasis, according to AJMC, adding a candidate…